Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - exemestane, quantity: 25 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; sodium starch glycollate type a; hypromellose; mannitol; microcrystalline cellulose; magnesium stearate; crospovidone; polysorbate 80; titanium dioxide; macrogol 400 - exemestane is indicated for the sequential adjuvant treatment of oestrogen receptor-positive early breast cancer in post-menopausal women who have received prior adjuvant tamoxifen therapy. . exemestane is indicated for the treatment of oestrogen receptor-positive advanced breast cancer in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy.

Malta - Kiingereza - Malta Medicines Authority

macleods pharma españa, s.l.u. avenida diagonal, 468, 6°, puerta a, 08006, barcelona, spain - nortriptyline hydrochloride - film-coated tablet - nortriptyline hydrochloride 10 mg - psychoanaleptics

Israeli - Kiingereza - Ministry of Health

abic marketing ltd, israel - exemestane - film coated tablets - exemestane 25 mg - exemestane - exemestane teva® is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. exemestane teva® is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies.exemestane teva® is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breast cancer following 2-3 years of initial adjuvant tamoxifen therapy

Israeli - Kiingereza - Ministry of Health

abic marketing ltd, israel - exemestane - film coated tablets - exemestane 25 mg - exemestane - exemestane teva® is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. exemestane teva® is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies.exemestane teva® is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breast cancer following 2-3 years of initial adjuvant tamoxifen therapy

Malta - Kiingereza - Malta Medicines Authority

pinewood laboratories ltd ballymacarbry, clonmel, co. tipperary, ireland - nortriptyline hydrochloride - film-coated tablet - nortriptyline hydrochloride 25 mg - psychoanaleptics

Malta - Kiingereza - Malta Medicines Authority

pinewood laboratories ltd ballymacarbry, clonmel, co. tipperary, ireland - nortriptyline hydrochloride - film-coated tablet - nortriptyline hydrochloride 50 mg - psychoanaleptics

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

ascot laboratories (ireland) limited - amitriptyline - film-coated tablet - 10 milligram(s) - non-selective monoamine reuptake inhibitors; amitriptyline

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

ascot laboratories (ireland) limited - amitriptyline hydrochloride - film-coated tablet - 25 milligram(s) - non-selective monoamine reuptake inhibitors; amitriptyline

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

creative pharma solutions s.r.o. - exemestane - film coated tablet - 25 milligram

Malta - Kiingereza - Malta Medicines Authority

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - amitriptyline hydrochloride - film-coated tablet - amitriptyline hydrochloride 10 mg - psychoanaleptics